ロード中...
Acute kidney injury and undiagnosed immunoglobulin A nephropathy after dabigatran therapy
Dabigatran, a new oral anticoagulant, is a direct thrombin inhibitor used as an alternative to warfarin to reduce the risk of stroke and systemic embolism with nonvalvular atrial fibrillation. We report a case of a man who resumed dabigatran after 6 weeks of prior therapy and began experiencing hema...
保存先:
| 出版年: | Proc (Bayl Univ Med Cent) |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5997039/ https://ncbi.nlm.nih.gov/pubmed/29904298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08998280.2018.1463036 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|